Haleon plc (HLN)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$10.02
-0.64%
Mkt Cap $45.70B
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$10.20
Range $10.20 – $10.20
Implied Upside
+1.8%
Consensus $10.20 vs current $10.02